GERN Geron Corporation

USD 1.39 -0.02 ( -1.42%)
Icon

Geron Corporation (GERN) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.39

-0.02 (-1.42%)

USD 0.88B

9.73M

USD 5.53(+297.93%)

N/A

Icon

GERN

Geron Corporation (USD)
COMMON STOCK | NSD
USD 1.39
-0.02 ( -1.42%)

Geron Corporation (GERN) Annual Income Statement (USD)

GERN Quarterly Financials (USD)

Frequently Asked Questions About Geron Corporation (GERN) Stock

Geron Corporation's (GERN) last reported annual revenue was USD 76.99 Million.

Geron Corporation's (GERN) annual revenue growth rate based on the revenue reported in the past 5 years is : 178.45%

Geron Corporation's(GERN) is not profitable as of its last reported annual financials.

The net profit margin for Geron Corporation's(GERN) from its laster reported year is -226.73%

The return on equity (ROE) for Geron Corporation's(GERN) from its last reported annual financials is : -66.09%

The return on assets (ROA) for Geron Corporation's(GERN) from its last reported annual financials is : -21.98%

The return on invested capital (ROIC) for Geron Corporation's(GERN) from its last reported annual financials is : -47.68%

The Debt to Equity ratio for Geron Corporation's(GERN) from its last reported annual financials is : 42.26%

The dividend yield for Geron Corporation's(GERN) from its laster reported year is 0.00%

Geron Corporation's(GERN) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...